ARCHIVES

NCI To Cut Smoking Intervention Study By 20%, Says Chemoprevention Accrual Has Priority

This article is from The Cancer Letter archive.

Vol. 18 No. 43 | November 6, 1992

Download PDF Visit The Full Archive

Related Articles

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

February 13, 1998

ODAC Unanimously Rejects Melblez, Citing Lower Survival

May 17, 2013

Memantine Can Delay Onset Of Cognitive Function Decline

November 30, 2012

Nexavar Improves PFS In Phase III Trial

January 25, 2013

Compromise on 6,000 Grants Would Make NCI Payline Around 163-164: Natcher Committee Close to Markup

June 28, 1985

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

May 31, 2013